(EMAILWIRE.COM, October 30, 2019 ) According to a new market research report " Anatomic Pathology Market by Product & Service (Instruments (Tissue Processing Systems, Microtome), Consumables (Reagent & Antibodies), Histopathology, Cytopathology), Application (Disease Diagnosis, Drug Discovery & Development) - Forecasts to 2021 " , published by MarketsandMarkets™.

The global anatomic pathology market is expected to reach USD 21.9 Billion by 2021 from USD 16.2 Billion in 2016, at a CAGR of 6.1% from 2016 to 2021.

Don’t miss the opportunities in global anatomic pathology market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145

Key players operating in the anatomic pathology market include F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific (U.S.), Danaher Corporation (U.S.), Agilent Technologies (U.S.), Sakura Finetechnical Co., Ltd. (Japan), Quest Diagnostics Incorporated (U.S.), Laboratory Corporation of America Holdings (U.S.), and NeoGenomics Laboratories, Inc. (U.S.).

Browse and in-depth TOC on "anatomic pathology market"

80 – Tables
32 – Figures
129 – Pages

Anatomic Pathology Market segmented into :

- On the basis of application, the anatomic pathology market is segmented into disease diagnosis, drug discovery & development, and other applications. The growth in this segment primarily attributed to increasing prevalence of chronic diseases.

- On the basis of product and service, the market is segmented into instruments, consumables, and services. This growth can be attributed to the increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests.

Get Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=137323145

Geographically, the anatomic pathology market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The growing prevalence of chronic diseases, rapidly increasing aging population, rising acceptance of personalized medicine, growing academic and government investments in diagnostic research, and the presence of a large number of major market players in this region are further driving the growth of this Anatomical pathology market.